Nutex Health, Inc.NUTXNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +269.77% | +213.98% | +220.69% | +239.87% | -41.12% |
| Gross Profit Growth | +971.84% | +1065.07% | +453.71% | +606.68% | -67.42% |
| EBITDA Growth | +0.00% | +772.59% | +156.89% | +1628.98% | -69.64% |
| Operating Income Growth | +0.00% | +4881.30% | +535.57% | +1249.17% | -72.93% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | -80.82% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | -85.80% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | -85.43% |
| Weighted Average Shares Growth | +26.78% | +22.64% | +10.90% | +31.40% | +31.40% |
| Weighted Average Shares Diluted Growth | +20.98% | +27.37% | +17.66% | +40.74% | +40.74% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +1570.44% | +105.56% | +1365.71% | +131561.74% |
| Free Cash Flow Growth | +0.00% | +2095.90% | +108.69% | +1507.37% | +0.00% |
| Receivables Growth | +276.02% | +355.29% | +435.32% | +483.91% | +35.33% |
| Inventory Growth | -15.95% | +4.79% | -17.56% | +39.79% | +0.57% |
| Asset Growth | +64.55% | +88.46% | +99.11% | +119.96% | +40.16% |
| Book Value per Share Growth | +87.83% | +155.04% | +238.13% | +299.37% | +71.33% |
| Debt Growth | +23.40% | +25.32% | +19.62% | +28.29% | +3.26% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +200.20% | +15.24% | +18.00% | -4.50% | -35.02% |